Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,000
Closed -$2.94M 63
2026
Q1
$2.94M Buy
20,000
+4,982
+33% +$810K 0.18% 30
2025
Q4
$2.93M Sell
15,018
-74,982
-83% -$17.9M 0.33% 27
2025
Q3
$25.3M Buy
90,000
+45,000
+100% +$11.5M 2.69% 11
2025
Q2
$9.84M Buy
45,000
+15,000
+50% +$2.42M 1.3% 17
2025
Q1
$4.19M Sell
30,000
-10,000
-25% -$1.63M 1.26% 20
2024
Q4
$6.67M Buy
+40,000
New +$7.11M 1.78% 20

Other funds holding ORCL

Proem Advisors's ORCL Position: Q2 2026 in Review

Proem Advisors sold out of Oracle (ORCL) in Q2 2026, closing a stake of 20,000 shares — an estimated $2.94M sold.

Proem Advisors first reported a position in ORCL in Q4 2024 and held it in 6 quarters. The position peaked at $25.3M in Q3 2025. 3,518 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Proem Advisors reported no remaining Oracle position as of Q2 2026 after selling out during the quarter.
  • Proem Advisors sold 20,000 Oracle shares in Q2 2026, an estimated $2.94M.
  • Proem Advisors first reported a position in Oracle in Q4 2024 and held it in 6 quarters.
  • Proem Advisors's Oracle position peaked at $25.3M in Q3 2025.
  • 3,518 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Proem Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.